FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Draft Guide on Cosmetic Registration/Listing

FDA issues a draft guidance entitled Registration and Listing of Cosmetic Product Facilities and Products: Guidance for Industry.

latest-news-card-1
Human Drugs

Astellas Eye Drug Approved by FDA

FDA approves an Astellas Pharmas Izervay (avacincaptad pegol intravitreal solution) for treating geographic atrophy secondary to age-related macular d...

latest-news-card-1
Human Drugs

FDA Clears Abbotts Hematology Device

FDA clears an Abbott 510(k)for its Alinity h-series hematology system for use by laboratories to run complete blood counts.

latest-news-card-1
Federal Register

Cubicin Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Cubist Pharmaceuticals Cubicin and Cubicin RF (daptomycin) powder for injection were not withdrawn due to...

latest-news-card-1
Federal Register

Comments Sought on 8 Drugs for WHO Scheduling

Federal Register notice: FDA seeks comments concerning abuse potential and the impact of scheduling changes on availability for medical use of eight d...

latest-news-card-1
Federal Register

Guide on Nitrosamine Acceptable Intake Limits

Federal Register notice: FDA makes available a final guidance entitled Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Imp...

latest-news-card-1
Human Drugs

Drger Recalls Carina Ventilators

Drgerwerk recalls its Drger Carina Sub-Acute Care Ventilators due to the potential for contamination of the breathing gas.

latest-news-card-1
Human Drugs

Orphan Status for BRAF Inhibitor

FDA grants ABM Therapeutics an orphan drug designation for ABM-1310, a novel small molecule BRAF inhibitor for treating patients with glioblastoma.

latest-news-card-1
Federal Register

Guide on Drug Supply Chain Security

Federal Register notice: FDA makes available a final guidance entitled Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the...

latest-news-card-1
Federal Register

K-TAB Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that KTAB (potassium chloride) extended-release tablets were not withdrawn due to safety or effectiveness conc...